No baby has ever been born from bone marrow-derived sperm or eggs. The technology, known as in vitro gametogenesis (IVG), remains in early laboratory stages, and no human pregnancy has been attempted. What exists so far are animal experiments, most conducted in mice, that offer a mixed picture: some offspring have been born alive, but many embryos fail before birth, and even the survivors show signs of hidden abnormalities.
What “Bone Marrow Babies” Actually Means
The idea comes from research showing that stem cells found in bone marrow can, under certain conditions, transform into cells resembling sperm or eggs. In 2007, researchers demonstrated that human bone marrow cells could develop early markers associated with male germ cells, the precursors to sperm. Separately, animal studies showed that when bone marrow stem cells were transplanted into mouse testes, neighboring cells in the testicular environment guided those stem cells to differentiate into both sperm-supporting cells and early-stage germ cells.
This is not the same as producing fully functional sperm or eggs ready for fertilization. The cells created so far are immature, and the leap from “expresses some of the right genetic markers” to “can fertilize an egg and produce a healthy embryo” is enormous.
What Animal Experiments Show
The closest researchers have come to creating offspring from lab-grown sex cells involved a related technique: growing mouse egg cells entirely outside the body and then fertilizing them. Some of those embryos did develop into live pups. But the success rate was low. Many embryos died before birth due to abnormal development. Even among the mice born apparently healthy, their placentas were abnormally heavy, a red flag suggesting developmental problems that weren’t immediately visible.
A review published in Science noted that these animals need to be monitored across multiple generations for problems with gene expression, behavior, longevity, and disease susceptibility. Some epigenetic errors, meaning problems with how genes are switched on and off rather than changes to the DNA code itself, can be passed down to future generations. So even a seemingly healthy first-generation animal could produce offspring with serious issues.
Why Embryos Fail: The Imprinting Problem
The biggest biological barrier is something called genomic imprinting. During normal reproduction, certain genes are chemically tagged so that only the copy from the mother or only the copy from the father is active. This tagging is essential for an embryo to develop properly. When researchers have created mouse embryos with genetic material from only one parent (two fathers or two mothers), the results are stark: embryos with two paternal copies fail to develop proper embryonic tissue, while embryos with two maternal copies fail to develop the placenta and supporting structures.
Lab-grown sex cells struggle to replicate these imprinting patterns correctly. Cloned animals created through nuclear transfer, a related technology, showed widespread imprinting instability and suffered from defects commonly associated with imprinting disorders. The concern is that stem cell-derived gametes would carry similar epigenetic errors, leading to miscarriage, birth defects, or health problems that only emerge later in life.
Regulatory Barriers to Human Use
Even if the science advanced rapidly, legal hurdles would prevent human trials for the foreseeable future. The FDA would have jurisdiction over IVG if it ever reached the clinical stage, but a Congressional funding rider currently prohibits the agency from even reviewing applications for research involving embryos with heritable genetic modifications. Whether IVG falls under that prohibition is debatable: the technology doesn’t intentionally modify genes, but it could unintentionally introduce heritable epigenetic changes, which a broad reading of the law would block.
At the state level, the landscape is a patchwork. Louisiana and South Dakota outright prohibit embryonic research. Several other states restrict the use of state funds for such work. The federal Dickey-Wicker Amendment, in place since 1995, bars federal money from being used to create embryos for research or to conduct research that destroys them. These overlapping restrictions mean that even basic IVG research involving human embryos is illegal or unfunded in much of the country.
A 2023 workshop convened by the National Academies of Sciences emphasized that because human IVG hasn’t been achieved yet, now is the window to define what safety benchmarks would need to be met before any clinical trial could begin.
How Far Away This Technology Is
Researchers have demonstrated that bone marrow cells can express some markers of early-stage sperm cells. They have not produced mature, functional human sperm or eggs from bone marrow. They have not fertilized a human egg with bone marrow-derived sperm. They have not created a human embryo this way, let alone brought one to term.
In mice, where the technology is furthest along, the process works poorly and produces offspring with suspected hidden health problems. Scaling that to humans introduces additional complexity: human reproductive biology is slower, less well understood at the cellular level, and subject to stricter quality control by the body itself. Most fertility researchers view bone marrow-derived reproduction as a long-term theoretical possibility, not something approaching clinical readiness.
For people searching this topic because of same-sex reproduction or fertility preservation after cancer treatment, the honest answer is that no proven path currently exists from bone marrow to a living child. Established alternatives like donor sperm, donor eggs, and embryo freezing before chemotherapy remain the practical options available today.